Michael Eberhardson

Publications

2026

Emelie Ljungström, Henrik Hjortswang, Michael Eberhardson, Katarina Pihl Lesnovska (2026) Negotiating Medication Adherence in Everyday Life with Inflammatory Bowel Disease: A Qualitative Study Patient Preference and Adherence, Vol. 20, Article 640901 (Article in journal) https://dx.doi.org/10.2147/PPA.S640901

Maie Abdalla, Michael Eberhardson, Kalle Landerholm, Roland Andersson, Pär Myrelid (2026) Impact of Inflammatory Bowel Disease and Primary Sclerosing Cholangitis on Colorectal Cancer Risk: National Cohort Study Clinical Gastroenterology and Hepatology, Vol. 24, p. 503-511 (Article in journal) https://dx.doi.org/10.1016/j.cgh.2025.06.037

2025

Åsa H. Everhov, Michael Eberhardson, Jonas Soderling, Caroline Nordenvall, Jonas Halfvarson, Jonas F. Ludvigsson, Ola Olen, Pär Myrelid, Swedish Inflammatory Bowel Disease Registry SWIBREG Study Grp (2025) Cumulative incidence and prevalence of perianal diseases in patients with inflammatory bowel disease and in the population: a nationwide Swedish study Scandinavian Journal of Gastroenterology, Vol. 60, p. 349-354 (Article in journal) https://dx.doi.org/10.1080/00365521.2025.2476669

Vilhelm Hjälte, Pär Myrelid, Henrik Hjortswang, Martin Rejler, Jonas F. Ludvigsson, Anders Forss, Marcus Bendtsen, Ola Olén, Åsa H. Everhov, Michael Eberhardson (2025) Substantial Reduction of Systemic Corticosteroid Use After Primary Ileocaecal Resection in Swedish Patients With Crohn's Disease: A Population-Based Cohort Study Alimentary Pharmacology and Therapeutics, Vol. 61, p. 1649-1661 (Article in journal) https://dx.doi.org/10.1111/apt.70069

2024

Joel Thunberg, Olle Granno, Daniel Bergemalm, Carl Eriksson, Isabella Visuri, Michael Eberhardson, Jonas Halfvarson (2024) Comparative study of a point-of-care test and an enzyme-linked immunosorbent assay (ELISA) for infliximab levels Scandinavian Journal of Gastroenterology, Vol. 59, p. 150-155 (Article in journal) https://dx.doi.org/10.1080/00365521.2023.2269456